Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannafora is an Israel-based medical cannabis treatment center focused on people with autism spectrum disorder and other neurodevelopmental disorders. The organization was founded by Abigail Dar and provides patient guidance, treatment support, and education around the use of medical cannabis, rather than developing its own drug pipeline. Its services appear to emphasize personalized treatment management, dosing guidance, family support, and practical expertise in cannabis-based care for pediatric and neurodevelopmental populations. Cannafora is healthcare-related, but it does not appear to be a traditional biotech or pharmaceutical company with proprietary therapeutics in clinical development. It is best characterized as a specialized clinical support and medical cannabis advisory center operating commercially in Israel.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CannaFora Center.